TIDMRGT 
 
For immediate release 
4 May 2010 
 
                             ReGen Therapeutics Plc 
 
                                Issue of Equity 
 
 
ReGen  Therapeutics  Plc  ("ReGen"  or  the  "Company"), (AIM:RGT) is pleased to 
announce  that it has conditionally placed 11,550,000 new ordinary shares at 2p 
per ordinary share to raise  GBP231,000 before expenses for general working capital 
purposes. 
 
The  11,550,000 new ordinary shares, which will  represent 18.75 per cent of the 
enlarged  issued  share  capital  of  the  Company  (in  aggregate  amounting to 
61,613,215 ordinary  shares on completion of the  placing), will rank pari passu 
in all respects with the existing ordinary shares in the Company. 
 
Application  has been  made to  the London  Stock Exchange  for the new ordinary 
shares to be admitted to trading on AIM and admission is expected to commence on 
or around Monday 10 May 2010. 
 
For further information, please contact: 
 
Percy Lomax 
ReGen Therapeutics Plc 
Tel: 020 7153 4920 
 
Roland Cornish/Felicity Geidt 
Beaumont Cornish Limited 
Tel: 020 7628 3396 
 
David Scott/Nick Bealer 
Alexander David Securities Limited 
Tel: 020 7448 9820 
 
ENDS 
 
 
[HUG#1411764]
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Argent Biopharma Charts.
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Argent Biopharma Charts.